Cancer & Oncology CME/CE Online Courses

Cancer Therapy CME/CE Courses

Cancer Therapy CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

1,800 Seconds™ in The Expanding Role of PARP Inhibitors in Ovarian Cancer

1,800 Seconds™ in The Expanding Role of PARP Inhibitors in Ovarian Cancer | myCME

AMA PRA Category 1 Credit(s)TM
A 30-minute video-based online module designed to provide an overview of current evidence on the expanding role of PARP inhibitors in the treatment of ovarian cancer. Dr. Kathleen Moore presents a patient case to provide context for a discussion of emerging data, ongoing clinical trials, and evidence-based strategies to support appropriate selection of patients for treatment with PARP inhibitors.
Targeted Treatments for Urothelial Cancer

Targeted Treatments for Urothelial Cancer

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s)
This activity will help advanced practitioners who treat patients with UC to know how to select and sequence these treatments.
Exploring Selection + Sequencing: A Multidisciplinary Tumor Board Discussion on Treatment Options for Patients With Advanced HCC

Exploring Selection + Sequencing: A Multidisciplinary Tumor Board Discussion on Treatment Options for Patients With Advanced HCC | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AANP Contact Hour(s)
The number of available systemic treatment options for advanced hepatocellular carcinoma (HCC) has rapidly increased over the last 3 years, providing new hope for patients but also new challenges in treatment selection and sequencing for healthcare professionals (HCPs). To help address these challenges, this 60-minute activity will allow you to “listen in” as a multidisciplinary team of experts discuss a patient case in a style similar to a tumor board meeting.
Matching the Tool to the Job: Individualizing Treatment Strategies in Ovarian Cancer

Individualizing Treatment Strategies in Ovarian Cancer | myCME

AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit
The landscape of maintenance treatment options for ovarian cancer has been rapidly evolving as new clinical trial data emerge. In this 30-minute, interactive activity, Drs Birrer and Matulonis will examine relevant data with regard to genetic and histologic markers that may guide individualization of therapy. Expert insights on effectively preventing and managing adverse events associated with maintenance therapy for ovarian cancer will be reviewed.
Immunotherapy for the Treatment of Melanoma and Lung Cancer

Immunotherapy for the Treatment of Melanoma and Lung Cancer | myCME

CNE Contact Hour(s)
This program will outline the necessary and unique skill sets of the nurse navigator; which includes a thorough knowledge of lung cancer and melanoma biology, treatments, and treatment side effects; the ability to address psychosocial issues; and expertise in accessing and navigating the healthcare system on behalf of their patients.
Closing the Disparity Gap and Optimizing HCC Care in the Hispanic Community

Closing Disparity Gap and Optimizing HCC Care in Hispanic Community | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
Significant race and ethnicity-specific disparities in HCC remain, particularly among Hispanics, who are more likely to present late and less likely to receive any HCC-directed treatment. To optimize care, clinicians must be vigilant about recognizing and addressing these disparities in care; and must also ensure and work towards Hispanic patients with HCC benefiting from the growing range of HCC management options.

Click for More Oncology Courses

Next hm-section-front in CME